Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) Return on Sales (2016 - 2025)

Historic Return on Sales for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to 0.02%.

  • Cross Country Healthcare's Return on Sales fell 300.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.01% for FY2024, which is 500.0% down from last year.
  • Per Cross Country Healthcare's latest filing, its Return on Sales stood at 0.02% for Q3 2025, which was down 300.0% from 0.02% recorded in Q2 2025.
  • Cross Country Healthcare's Return on Sales' 5-year high stood at 0.12% during Q4 2021, with a 5-year trough of 0.05% in Q2 2024.
  • For the 5-year period, Cross Country Healthcare's Return on Sales averaged around 0.03%, with its median value being 0.03% (2021).
  • As far as peak fluctuations go, Cross Country Healthcare's Return on Sales skyrocketed by 1000bps in 2021, and later tumbled by -900bps in 2024.
  • Over the past 5 years, Cross Country Healthcare's Return on Sales (Quarter) stood at 0.12% in 2021, then crashed by -52bps to 0.06% in 2022, then tumbled by -62bps to 0.02% in 2023, then plummeted by -155bps to 0.01% in 2024, then crashed by -58bps to 0.02% in 2025.
  • Its Return on Sales was 0.02% in Q3 2025, compared to 0.02% in Q2 2025 and 0.0% in Q1 2025.